Children face higher mortality in DRC Ebola outbreak due to limited pediatric medicines

The Democratic Republic of Congo is confronting a new Ebola virus outbreak that has already shown a disproportionate impact on children, who are dying at higher rates than adults. Health officials from the Ministry of Health and the World Health Organization (WHO) reported that pediatric fatalities account for roughly 60 % of the total deaths recorded since the outbreak began in early August, a stark contrast to previous epidemics where adult mortality was higher. While the virus itself is a primary factor, experts emphasize that limited access to age‑appropriate therapeutics is exacerbating the risk for younger patients.

Supply chain constraints and regulatory hurdles have delayed the distribution of medicines specifically formulated for children, such as monoclonal antibody treatments and antiviral regimens that require pediatric dosing. International partners are working to expedite approvals and shipments, but logistical challenges in remote regions and the need for cold‑chain storage continue to impede timely delivery. Authorities are urging accelerated procurement and the establishment of dedicated pediatric treatment centers to reduce the mortality gap as the outbreak progresses.